•
Sep 30, 2024

Repligen Q3 2024 Earnings Report

Repligen's Q3 2024 performance was marked by a 10% year-over-year revenue increase, driven by strong CDMO and equipment sales, along with record new modality sales, and the company narrowed its full-year revenue guidance.

Key Takeaways

Repligen reported a strong third quarter with a 10% increase in revenue compared to the previous year. The company saw growth in CDMO and equipment sales, as well as record sales in new modalities. Full year revenue guidance was narrowed to $630-$639 million.

Repligen reported Q3 revenue of $155 million, a 10% increase year-over-year.

CDMO revenue and orders both increased by approximately 20% year-over-year.

Overall order intake surpassed sales by 4%.

Full year revenue guidance was narrowed to a range of $630-$639 million.

Total Revenue
$155M
Previous year: $141M
+9.7%
EPS
$0.43
Previous year: $0.23
+87.0%
Gross Margin
50%
Previous year: 25.9%
+93.1%
Gross Profit
$77M
Previous year: $36.6M
+110.4%
Cash and Equivalents
$784M
Previous year: $631M
+24.3%
Free Cash Flow
$42.2M
Previous year: $30.8M
+36.8%
Total Assets
$2.83B
Previous year: $2.51B
+12.6%

Repligen

Repligen

Repligen Revenue by Segment

Forward Guidance

Repligen narrowed its full year 2024 revenue guidance to a range of $630M - $639M.

Revenue & Expenses

Visualization of income flow from segment revenue to net income